|
US3481942A
(en)
*
|
1968-09-06 |
1969-12-02 |
Smithkline Corp |
Oxa-diazaspiro(4.5)decane compounds
|
|
JPS60208590A
(ja)
*
|
1984-03-30 |
1985-10-21 |
株式会社日立製作所 |
エレベ−タ−敷居装置
|
|
EP0189370A3
(de)
*
|
1985-01-16 |
1988-01-27 |
Sandoz Ag |
Spiro-dioxolane, -dithiolane und -oxothiolane
|
|
DE3501225A1
(de)
*
|
1985-01-16 |
1986-07-24 |
Sandoz-Patent-GmbH, 7850 Lörrach |
Spirodioxolane, ihre herstellung und verwendung
|
|
US4855290A
(en)
*
|
1985-05-10 |
1989-08-08 |
State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research |
Derivatives of quinuclidine
|
|
US5179079A
(en)
|
1986-12-16 |
1993-01-12 |
Novo Nordisk A/S |
Nasal formulation and intranasal administration therewith
|
|
JPS63208590A
(ja)
*
|
1987-02-24 |
1988-08-30 |
Yamanouchi Pharmaceut Co Ltd |
ヘテロ環式スピロ化合物及びその製造法
|
|
JPS63208844A
(ja)
*
|
1987-02-26 |
1988-08-30 |
Konica Corp |
有機着色物質の光褪色防止方法
|
|
US4981858A
(en)
|
1987-08-13 |
1991-01-01 |
State Of Israel, Represented By The Prime Minister's Office, Israel Institute For Biological Research |
Optical isomers
|
|
IL87234A
(en)
*
|
1987-08-13 |
1992-02-16 |
Israel Inst Biolog Res |
Optical isomers of 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine,their preparation and pharmaceutical compositions containing them
|
|
ATE122353T1
(de)
*
|
1987-10-05 |
1995-05-15 |
Yamanouchi Pharma Co Ltd |
Heterozyklische spiroverbindungen und ihre herstellung.
|
|
US4900830A
(en)
|
1987-10-28 |
1990-02-13 |
Israel Institute For Biological Research |
Process for labelling sulfur-containing compounds
|
|
US4876260A
(en)
|
1987-10-28 |
1989-10-24 |
State Of Israel, Israel Institute Of Biological Research |
Oxathiolanes
|
|
IT1223343B
(it)
|
1987-11-03 |
1990-09-19 |
Also Lab Sas |
Formulazioni farmaceutiche per somministrazione transdermica
|
|
GB8808433D0
(en)
*
|
1988-04-11 |
1988-05-11 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB8816299D0
(en)
*
|
1988-07-08 |
1988-08-10 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US5053412A
(en)
|
1990-04-10 |
1991-10-01 |
Israel Institute For Biological Research |
Spiro nitrogen-bridged heterocyclic compounds
|
|
JPH02164882A
(ja)
|
1988-12-20 |
1990-06-25 |
Yamanouchi Pharmaceut Co Ltd |
スピロ化合物及びその中間体
|
|
US4994439A
(en)
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
|
AU5194990A
(en)
|
1989-02-23 |
1990-09-26 |
Rorer International (Holdings), Inc. |
Therapeutic aerosol formulations
|
|
US5075317A
(en)
*
|
1989-06-21 |
1991-12-24 |
Fisons Corporation |
Spirofurane derivatives
|
|
GB8921222D0
(en)
|
1989-09-20 |
1989-11-08 |
Riker Laboratories Inc |
Medicinal aerosol formulations
|
|
US5221675A
(en)
*
|
1989-12-15 |
1993-06-22 |
Abbott Laboratories |
Aza-spirocyclic compounds that enhance cholinergic neurotransmission
|
|
US5852029A
(en)
|
1990-04-10 |
1998-12-22 |
Israel Institute For Biological Research |
Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
|
|
IL97726A
(en)
*
|
1990-04-10 |
1994-12-29 |
Israel Inst Biolog Res |
Pharmaceutical compositions containing compounds with bridged and unbridged heterocyclic groups, spiro-connected with oxazoline and thiazoline groups, and some new such compounds
|
|
US5534520A
(en)
*
|
1990-04-10 |
1996-07-09 |
Fisher; Abraham |
Spiro compounds containing five-membered rings
|
|
US5407938A
(en)
*
|
1990-04-10 |
1995-04-18 |
Israel Institute For Biological Research |
Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
|
|
US5230884A
(en)
|
1990-09-11 |
1993-07-27 |
University Of Wales College Of Cardiff |
Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
|
|
US5292499A
(en)
|
1990-09-11 |
1994-03-08 |
University Of Wales College Of Cardiff |
Method of preparing medical aerosol formulations including drug dissolved in reverse micelles
|
|
US5403931A
(en)
*
|
1991-05-15 |
1995-04-04 |
Yamanouchi Pharmaceutical Co., Ltd. |
(-)-(S)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane L-tartrate
|
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
|
US5707641A
(en)
|
1994-10-13 |
1998-01-13 |
Pharmaderm Research & Development Ltd. |
Formulations comprising therapeutically-active proteins or polypeptides
|
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
|
CH689139A5
(de)
|
1995-04-03 |
1998-10-30 |
Cerbios Pharma Sa |
Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
|
|
US6309671B1
(en)
|
1995-04-14 |
2001-10-30 |
Inhale Therapeutic Systems |
Stable glassy state powder formulations
|
|
US5635161A
(en)
|
1995-06-07 |
1997-06-03 |
Abbott Laboratories |
Aerosol drug formulations containing vegetable oils
|
|
US6120794A
(en)
|
1995-09-26 |
2000-09-19 |
University Of Pittsburgh |
Emulsion and micellar formulations for the delivery of biologically active substances to cells
|
|
EP0801557B1
(en)
|
1995-10-12 |
2003-07-02 |
Supergen, Inc. |
Liposome formulations of 5beta steroids
|
|
DE19637043A1
(de)
*
|
1996-09-12 |
1998-03-19 |
Boehringer Mannheim Gmbh |
Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel und Reagenzien
|
|
BR9911031A
(pt)
|
1998-05-20 |
2002-01-29 |
Liposome Co Inc |
Novas formulações em partìculas
|
|
US6451349B1
(en)
|
1998-08-19 |
2002-09-17 |
Quadrant Healthcare (Uk) Limited |
Spray-drying process for the preparation of microparticles
|
|
GB9814172D0
(en)
|
1998-06-30 |
1998-08-26 |
Andaris Ltd |
Formulation for inhalation
|
|
AUPP494798A0
(en)
|
1998-07-29 |
1998-08-20 |
Pacific Biolink Pty Limited |
Protective protein formulation
|
|
US6290987B1
(en)
|
1998-09-27 |
2001-09-18 |
Generex Pharmaceuticals, Inc. |
Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
|
|
WO2000023444A1
(en)
*
|
1998-10-21 |
2000-04-27 |
Abbott Laboratories |
5,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
|
|
US6294153B1
(en)
|
1998-12-21 |
2001-09-25 |
Generex Pharmaceuticals, Inc. |
Aerosol pharmaceutical formulation for pulmonary and nasal delivery
|
|
EP1338272A1
(en)
|
1998-12-21 |
2003-08-27 |
Generex Pharmaceuticals Inc. |
Aerosol formulations for buccal and pulmonary application comprising chenodeoxycholate or deoxycholate
|
|
US6436367B1
(en)
|
1998-12-21 |
2002-08-20 |
Generex Pharmaceuticals Inc. |
Aerosol formulations for buccal and pulmonary application
|
|
BR0007974A
(pt)
|
1999-02-03 |
2001-10-30 |
Powderject Res Ltd |
Usos de um agente farmacologicamente ativo, deum constructo de gene e de um antìgeno, métodospara produzir uma composição farmacêutica em póe para administrar uma droga a um indivìduo emnecessidade dela, composição farmacêutica, formade dosagem unitária, e, artigo de manufatura parasuprimento transdérmico ou transmucoso de umagente farmacologicamente ativo a um indivìduo
|
|
EP1158961A1
(en)
|
1999-03-08 |
2001-12-05 |
PowderJect Research Limited |
Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
|
|
AU3957400A
(en)
|
1999-04-16 |
2000-11-02 |
Novo Nordisk A/S |
Dry, mouldable drug formulation
|
|
JP2003501404A
(ja)
|
1999-06-04 |
2003-01-14 |
デルルックス ファーマシューティカル コーポレイション |
薬剤の脱水粒子からなる製剤およびこれの調製方法
|
|
US20010036481A1
(en)
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
|
CA2382821A1
(en)
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
|
MXPA02007052A
(es)
|
2000-01-20 |
2002-12-13 |
Basilea Pharmaceutica Ag |
Composiciones que se administran nasalmente y que contienen peptidos ciclicos.
|
|
EP1129705A1
(en)
|
2000-02-17 |
2001-09-05 |
Rijksuniversiteit te Groningen |
Powder formulation for inhalation
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
GB0009468D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
|
CA2406206C
(en)
|
2000-04-17 |
2012-03-20 |
Vectura Limited |
Improvements in or relating to formulations for use in inhaler devices
|
|
AU2001290678A1
(en)
|
2000-09-08 |
2002-03-22 |
Powderject Research Limited |
Alginate particle formulation
|
|
FI20002768L
(fi)
|
2000-12-18 |
2002-06-19 |
Licentia Oy |
Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
|
|
GB0107106D0
(en)
|
2001-03-21 |
2001-05-09 |
Boehringer Ingelheim Pharma |
Powder inhaler formulations
|
|
DE10130020A1
(de)
*
|
2001-06-25 |
2003-12-04 |
Gruenenthal Gmbh |
Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate
|
|
US20030019437A1
(en)
|
2001-07-26 |
2003-01-30 |
John Fore |
Ungulate game animal feed system and method
|
|
ES2307779T3
(es)
|
2001-08-16 |
2008-12-01 |
Baxter International Inc. |
Formulaciones de microparticulas a base de propelentes.
|
|
WO2003072080A1
(en)
|
2002-02-22 |
2003-09-04 |
Advanced Inhalation Research, Inc. |
Inhalable formulations for sustained release
|
|
AU2003230689B2
(en)
|
2002-03-20 |
2006-06-29 |
Alkermes, Inc. |
Inhalable sustained therapeutic formulations
|
|
MXPA04010921A
(es)
*
|
2002-05-03 |
2005-05-27 |
Israel Inst Biolog Res |
Metodos y composiciones para el tratamietno de trastornos del sistema nervioso central y periferico y compuestos novedosos utiles para los mismos.
|
|
CA2484724C
(en)
|
2002-05-07 |
2007-01-16 |
Ferring B.V. |
Pharmaceutical formulations
|
|
DE10323244A1
(de)
|
2003-05-22 |
2004-12-16 |
Infineon Technologies Ag |
Integrierte Speicher-Schaltungsanordnung, insbesondere UCP-Flash-Speicher
|
|
DE102005030051A1
(de)
*
|
2005-06-27 |
2006-12-28 |
Grünenthal GmbH |
Substituierte 1-Oxa-3,8-diazaspiro[4,5]-decan-2-on-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
|
JP2010155827A
(ja)
*
|
2008-12-04 |
2010-07-15 |
Takeda Chem Ind Ltd |
スピロ環化合物
|
|
KR20150116466A
(ko)
*
|
2009-01-26 |
2015-10-15 |
이스라엘 인스티튜트 포 바이올로지컬 리서치 |
이환형 헤테로사이클릭 스피로 화합물
|